Cholera Toxin Treatment Increasesin VivoGrowth and Development of the Mouse Mammary Gland*
- 1 November 1985
- journal article
- research article
- Published by The Endocrine Society in Endocrinology
- Vol. 117 (5) , 1864-1869
- https://doi.org/10.1210/endo-117-5-1864
Abstract
Daily sc injections of cholera toxin (CT; 0.1 .mu.g/day), a stimulator of adenylate cyclase activity, into intact female BALB/c mice for 20 days significantly (P < 0.05) increased mammary gland development scores from 2.0 .+-. 0.1 in controls to 3.6 .+-. 0.2 in CT-treated mice. Concurrent administration of 17.beta.-estradiol (E; 1.0 .mu.g/day) and progesterone (P; 1.0 mg/day) resulted in development scores of 4.1 .+-. 0.1 and 5.2 .+-. 0.1 in E/P and E/P + CT treatment groups, respectively (P < 0.05). If mice were ovariectomized before CT injection, the response to CT alone was abolished (development scores of 2.0 .+-. 0.1 and 1.9 .+-. 0.1 in controls and CT-treated mice, respectively). However, E/P restored the response to CT (scores of 3.2 .+-. 0.2 for E/P and 4.0 .+-. 0.1 for E/P + CT; P < 0.05) in ovariectomized mice. CT significantly (P < 0.05) increased mammary dry fat-free tissue weight from 2.89 .+-. 0.41 mg (controls) to 3.78 .+-. 0.37 mg (CT-treated) and from 4.03 .+-. 0.59 mg (E/P-treated) to 5.42 .+-. 0.91 mg (E/P + CT). Similary, CT treatment increased mammary DNA from 138.7 .+-. 11.7 .mu.g (controls) to 162.8 .+-. 14.4 .mu.g (CT) and from 178.5 .+-. 12.6 to 233.9 .+-. 28.0 .mu.g in the presence of E/P (P < 0.05). Furthermore, CT was found to be mammogenic in hypophysectomized mice treated with E (1.0 .mu.g/day), P (1.0 mg/day), deoxycorticosterone acetate (0.5 mg/day), T4 (0.2 .mu.g/ml drinking water), and glucose (50 mg/ml drinking water), i.e. mammary gland development scores were 1.5 .+-. 0.1 in mice treated with the above regimen and 3.1 .+-. 0.1 in mice treated with the above regimen plus CT for 14 days (P < 0.05). These results provided clear evidence, heretofore unreported, that systemic CT treatment increased mammary gland development and growth in femal mice. The mammogenic effects of CT are observed in intact female mice with or without exogenous E/P, in ovariectomized mice treated with E/P, and in hypophysectomized mice treated with E/P, deoxycortisone acetate, and T4.This publication has 15 references indexed in Scilit:
- The Regulation of Luteinizing Hormone and Prolactin in C57BL/6J Mice: Effects of Estradiol Implant Size, Duration of Ovariectomy, and Aging*Endocrinology, 1984
- Cyclic AMP changes in guinea pig mammary gland and milkAmerican Journal of Physiology-Endocrinology and Metabolism, 1983
- Influence of cholera toxin on the growth and development of N-methyl-N-nitrosourea-induced rat mammary carcinomasCancer Letters, 1983
- ANTICARCINOGENIC EFFECT OF N6,O2'-DIBUTYRYL CYCLIC ADENOSINE 3'-5'-MONOPHOSPHATE ON 7,12-DIMETHYLBENZ(A)ANTHRACENE MAMMARY-TUMOR INDUCTION IN THE RAT AND ITS RELATIONSHIP TO CYCLIC ADENOSINE 3'-5'-MONOPHOSPHATE METABOLISM AND PROTEIN-KINASE1983
- Effects of dopamine on prolactin secretion and cyclic AMP accumulation in the rat anterior pituitary glandBiochemical Journal, 1981
- Growth Factor- and Cyclic Nucleotide-Induced Proliferation of Normal and Malignant Mammary Epithelial Cells in Primary Culture*Endocrinology, 1980
- Cholera toxin and analogues of cyclic AMP stimulate the growth of cultured human mammary epithelial cellsJournal of Cellular Physiology, 1980
- Increase of cyclic AMP-dependent protein kinase type II as an early event in hormone-dependent mammary tumor regressionBiochemical and Biophysical Research Communications, 1978
- PROPHYLAXIS OF SPONTANEOUSLY DEVELOPING MAMMARY-CARCINOMA IN C3H/HEJ FEMALE MICE BY SUPPRESSION OF PROLACTIN1973
- A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acidBiochemical Journal, 1956